(R)-(+)-3-<(benzyloxy)methoxy>-2-methylpropanol | 102518-03-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (R)-(+)-3-<(benzyloxy)methoxy>-2-methylpropanol
• 英文别名: (2R)-3-Benzyloxymethoxy-2-methyl-propan-1-ol；(2R)-2-methyl-3-(phenylmethoxymethoxy)propan-1-ol
• CAS: 102518-03-6
• 化学式: C₁₂H₁₈O₃
• 分子量: 210.273
• InChiKey: OGELSYWTTDHGTD-LLVKDONJSA-N

物化性质

• 沸点：
  324.5±22.0 °C(Predicted)
• 密度：
  1.057±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (R)-(+)-3-<(benzyloxy)methoxy>-2-methylpropanol 以70%的产率得到(S)-(+)-3-<(benzyloxy)methoxy>-2-methylpropanal
  参考文献：
  名称：

  Synthesis of an avermectin-nemadectin hybrid.

  摘要：

  The Wittig condensation of (2R,3R,4E)-2,6-dimethyl-3-trimethylsilyloxy-4-heptenyltriphenylphosphorylidene with aldehyde 1 produced the desired cis olefin 11 in 45% yield. Treatment of this intermediate with pyridinium tosylate in methanol effected spiroketalization and desilylation with hydrogen fluoride-pyridine in THF afforded the avermectin-nemadectin hybrid 2.

  DOI：

  10.1016/s0040-4039(00)79760-7
• 作为产物：
  描述：

  苄基氯甲基醚 在 lithium aluminium tetrahydride 、 N,N-二异丙基乙胺 作用下， 以 乙醚 为溶剂， 反应 3.0h， 生成 (R)-(+)-3-<(benzyloxy)methoxy>-2-methylpropanol
  参考文献：
  名称：

  Synthesis of an avermectin-nemadectin hybrid.

  摘要：

  The Wittig condensation of (2R,3R,4E)-2,6-dimethyl-3-trimethylsilyloxy-4-heptenyltriphenylphosphorylidene with aldehyde 1 produced the desired cis olefin 11 in 45% yield. Treatment of this intermediate with pyridinium tosylate in methanol effected spiroketalization and desilylation with hydrogen fluoride-pyridine in THF afforded the avermectin-nemadectin hybrid 2.

  DOI：

  10.1016/s0040-4039(00)79760-7

文献信息

• Stereocontrolled and Convergent Total Synthesis of Amphidinolide T3
  作者：Li-Sheng Deng、Xiao-Ping Huang、Gang Zhao

  DOI：10.1021/jo0605086

  日期：2006.6.1

  Stereocontrolled and convergent total synthesis of amphidinolide T3 has been described. A retrosynthetic scheme was constructed that led to the recognition of readily available and enantiomerically related compounds as starting materials for the total synthesis of amphidinolide T3. Thus, the two key building blocks 6 and 7 were defined as subtargets and synthesized in optically active forms. The C1−C12

  已经描述了立体控制的和会聚的安非他命T3的全合成。构建了逆合成方案，该方案导致了容易获得的和对映异构相关的化合物被识别为完全合成两性霉素T3的起始原料。因此，将两个关键构件6和7定义为子目标，并以光学活性形式合成。C1-C12片段6衍生自市售的d-谷氨酸或其合成等效物（R）-5-羟甲基四氢呋喃-2-酮16，作为起始原料，涉及高度非对映选择性不对称烯丙基化为关键步骤。C13-C21片段7通过链段10和碘化物11的二噻吩偶联，以高收率高效地合成苯并噻吩，随后进行脱保护和Petasis烯化。最终，片段醛6和二噻吩7的组装以及C-C键的形成，两步氧化还原序列，选择性大环内酯化和功能转变提供了两性化合物A3和T4的收敛的全部和形式合成，这种方法还提供了一种灵活而实用的两性霉素T大环内酯的合成方法。
• Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3
  申请人：DeLuca F. Hector

  公开号：US20070112077A1

  公开（公告）日：2007-05-17

  Des-C,D 2-methylene-19-norvitamin D 3 analogs are provided including compounds of formula 1, in which R 1 is a straight or branched chain alkyl or alkylene group having from 8 to 27 carbons and bearing an Oy 3 group; and y 1 , y 2 and y 3 are independently selected from H or hydroxy-protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions.

  提供了Des-C、D 2-亚甲基-19-去氢维生素D3类似物，包括式1中的化合物，其中R1是具有8至27个碳的直链或支链烷基或烷基烯基基团，并带有一个Oy3基团；而y1、y2和y3是独立选择的H或羟基保护基团。这些化合物可用于制备药物组合物，并可用于治疗各种生物学情况。
• Des-C,D analogs of 1α,25-dihydroxy-19-norvitamin D3
  申请人：Wisconsin Alumni Research Foundation

  公开号：US07534777B2

  公开（公告）日：2009-05-19

  Des-C,D 2-methylene-19-norvitamin D3 analogs are provided including compounds of formula 1, in which R1 is a straight or branched chain alkyl or alkylene group having from 8 to 27 carbons and bearing an OY3 group; and Y1, Y2 and Y3 are independently selected from H or hydroxy-protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions.

  提供了Des-C，D 2-亚甲基-19-去维生素D3类似物，其中包括式子1的化合物，其中R1是直链或支链烷基或烷基链，具有8到27个碳，并带有一个OY3基团；Y1，Y2和Y3是独立选择的H或羟基保护基团。这些化合物可用于制备药物组合物，并且在治疗各种生物状况方面有用。
• Synthetic study on oscillatoxin D: Construction of the C1–C26 spiroether segment by intramolecular aldol condensation and Michael-type addition
  作者：Hiroaki Toshima、Takashi Goto、Akitami Ichihara

  DOI：10.1016/s0040-4039(00)73355-7

  日期：1994.6

  The C-1-C-7 segment (10) and the C-8-C-21 segment (14) of oscillatoxin D have been synthesized efficiently. The acyclic compound obtained by coupling of these two segments, has been converted int the C-1-C-26 spiroether (18) possessing the same stereogenic centers of oscillatoxin D. The construction of the spiroether has been achieved by intramolecular aldol condensation and Michael-type addition as key steps.
• BOECKMAN, ROBERT K. (JR);CHARETTE, ANDRE B.;ASBEROM, THEODROS;JOHNSTON, B+, J. AMER. CHEM. SOC., 113,(1991) N, C. 5337-5353
  作者：BOECKMAN, ROBERT K. (JR)、CHARETTE, ANDRE B.、ASBEROM, THEODROS、JOHNSTON, B+

  DOI：——

  日期：——